Literature DB >> 8949571

Ethnicity affects IGFBP-3 and IGF-II in normal healthy young adult subjects.

K D Hopkins1, E D Lehmann, R L Jones, J M Holly, S C Cwyfan-Hughes, R C Turay, J D Teale, R G Gosling.   

Abstract

OBJECTIVE: While the effects of age on the growth hormone/insulin-like growth factor (IGF) axis are well documented, the influence of ethnic background is unknown. The differences in IGF and IGF binding proteins (IGFBPs) were investigated in two ethnic groups.
DESIGN: A cross-sectional study of an age-selected cohort of healthy, normoglycaemic, non-obese Caucasian (C) and Asian (A) subjects. PATIENTS: Fifty-three (27 C, 26 A) subjects with a mean age (+/- SD) of 20.6 +/- 0.8 years were studied. MEASUREMENTS: Fasting measurements of glucose, insulin, IGF-I, IGF-II, IGFBP-1 and IGFBP-3. Western ligand blotting and immunoblotting with IGFBP-2 and IGFBP-3 of serum samples.
RESULTS: There were no significant differences in IGF-I levels between Caucasian and Asian subjects (C 218 +/- 55 vs A 229 +/- 40 micrograms/l; P = 0.44). IGF-II (C 707 +/- 110 vs A 583 +/- 75 micrograms/l; P < 0.0001) and IGFBP-3 (C 5.9 +/- 1.2 vs A 5.12 +/- 1.17 mg/l; P = 0.01) levels were significantly higher in Caucasian subjects. Immunoblotting of ligand blots revealed no protease activity on either IGFBP-3 or IGFBP-2 to account for these ethnic differences.
CONCLUSIONS: Ethnic differences in IGFBP-3 and associated IGF-II levels may affect the inter-relationships of IGFs and their binding proteins and need to be considered when interpreting IGF data on growth and metabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8949571     DOI: 10.1046/j.1365-2265.1996.00815.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

Review 1.  Diabetes and ethnic minorities.

Authors:  J Oldroyd; M Banerjee; A Heald; K Cruickshank
Journal:  Postgrad Med J       Date:  2005-08       Impact factor: 2.401

2.  Comment re: Premenopausal mammographic density and hormone levels.

Authors:  Pagona Lagiou; Dimitrios Trichopoulos; Chung-Cheng Hsieh
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

3.  Insulin-like growth factor-II in adipocyte regulation: depot-specific actions suggest a potential role limiting excess visceral adiposity.

Authors:  Maiadah N Alfares; Claire M Perks; Julian P Hamilton-Shield; Jeffrey M P Holly
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-07-24       Impact factor: 4.310

4.  Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients.

Authors:  Carlos Fernández-Pereira; Maria Aránzazu Penedo; Tania Rivera-Baltanas; Rafael Fernández-Martínez; Saida Ortolano; José Manuel Olivares; Roberto Carlos Agís-Balboa
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

5.  Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia.

Authors:  Yuan-Jian Yang; Tao Luo; Ying Zhao; Shu-Zhen Jiang; Jian-Wen Xiong; Jin-Qiong Zhan; Bin Yu; Kun Yan; Bo Wei
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.